{"DataElement":{"publicId":"3170119","version":"1","preferredName":"Distribution Epitope Other Neoplasm Or Tissue Disease Finding Type","preferredDefinition":"The particular kind of disease finding about the distribution of epitope in other tissues or tumors.","longName":"DS_EP_OT_TMTS_DFN_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3170106","version":"1","preferredName":"Distribution Epitope Other Neoplasm Or Tissue","preferredDefinition":"The distribution of epitope in other tissues or tumors.","longName":"DISTB_EPIT_TMR_TIS","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3170103","version":"1","preferredName":"Distribution Epitope","preferredDefinition":"The act of distributing or spreading or apportioning.:The simplest form of an antigenic determinant, on a complex antigenic molecule, which can combine with antibody or T cell receptor.","longName":"C45273:C13189","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Distribution","conceptCode":"C45273","definition":"The act of distributing or spreading or apportioning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Epitope","conceptCode":"C13189","definition":"The simplest form of an antigenic determinant, on a complex antigenic molecule, which can combine with antibody or T cell receptor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"978E3949-9EB9-79C9-E040-BB89AD4309C8","latestVersionIndicator":"Yes","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"ONEDATA","dateModified":"2010-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3170104","version":"1","preferredName":"Other Neoplasm Or Tissue","preferredDefinition":"Different than the one(s) previously specified or mentioned.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","longName":"C17649:C3262:C37998:C12801","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"978E3949-9ECC-79C9-E040-BB89AD4309C8","latestVersionIndicator":"Yes","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"ONEDATA","dateModified":"2010-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"978E3949-9EDD-79C9-E040-BB89AD4309C8","latestVersionIndicator":"Yes","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3170116","version":"1","preferredName":"Neoplasm Or Tissue Disease Disorder or Finding Type","preferredDefinition":"The particular kind of disease finding about the other tissues or tumors.","longName":"TMR_TIS_DIS_FND_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"normal","valueDescription":"Normal","ValueMeaning":{"publicId":"2567281","version":"1","preferredName":"Normal","longName":"2567281","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3DE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"978E3949-9F6F-79C9-E040-BB89AD4309C8","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"ONEDATA","dateModified":"2010-12-16","deletedIndicator":"No"},{"value":"both","valueDescription":"Both","ValueMeaning":{"publicId":"2558322","version":"1","preferredName":"Both","longName":"2558322","preferredDefinition":"Two entities considered and identifed together.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Both","conceptCode":"C49636","definition":"One and the other; relating to or being two in conjunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0DF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"978E3949-9F4F-79C9-E040-BB89AD4309C8","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"ONEDATA","dateModified":"2010-12-16","deletedIndicator":"No"},{"value":"cancer","valueDescription":"Malignant Neoplasm","ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"978E3949-9F64-79C9-E040-BB89AD4309C8","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"ONEDATA","dateModified":"2010-12-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3170115","version":"1","preferredName":"Neoplasm Or Tissue Disease, Disorder or Finding Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.:Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included. [Source: NCI]:Type; a subdivision of a particular kind of thing.","longName":"3170115v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease, Disorder or Finding","conceptCode":"C7057","definition":"A condition that is relevant to human neoplasms and non-neoplastic disorders.  This includes observations, test results, history and other concepts relevant to the characterization of human pathologic conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"978E3949-9F2B-79C9-E040-BB89AD4309C8","latestVersionIndicator":"Yes","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"ONEDATA","dateModified":"2010-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"978E3949-9F3C-79C9-E040-BB89AD4309C8","latestVersionIndicator":"Yes","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"COOPERM","dateModified":"2017-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2939361","version":"1","longName":"DCTD (Division of Cancer Treatment and Diagnosis)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3165540","version":"1","longName":"Immunohistochemical Biomarker","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is distribution of epito","type":"Preferred Question Text","description":"What is distribution of epitope in other tissues or tumors?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"978E7A62-A40D-5AA4-E040-BB89AD433D43","latestVersionIndicator":"Yes","beginDate":"2010-12-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-12-16","modifiedBy":"MAESKEB","dateModified":"2011-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}